100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
- Authors
- Type
- Published Article
- Journal
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier
- Volume
- 73
- Issue
- 4
- Pages
- 645–645
- Identifiers
- DOI: 10.1016/j.jaad.2015.06.060
- Source
- maverakislab-ucdavis dermatology-ucdavis
- License
- Unknown